Global Antimicrobial Wound Dressing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Antimicrobial Wound Dressing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Antimicrobial wound dressings are wound covers that alter the wound bed bioburden. Indicated to help prevent infection and provide protection from common infectious bacteria and other contaminants. Many antimicrobial wound dressings are impregnated with common agents such as polyhexamethylene biguanide (PHMB) or ionic silver while others are designed to treat without such agents.

Market Overview:

The latest research study on the global Antimicrobial Wound Dressing market finds that the global Antimicrobial Wound Dressing market reached a value of USD 3330.41 million in 2022. It’s expected that the market will achieve USD 4545.31 million by 2028, exhibiting a CAGR of 5.32% during the forecast period.

Market Opportunities and Drivers

As a medical hygiene material, the demand for antimicrobial wound dressings is rigid, without obvious cyclicality and seasonality, and the industry downstream is mainly for hospitals, community clinics, OTC pharmacies and other medical institutions, mainly through agents, hospitals, pharmacies and other channels of distribution. In the context of aging and strengthening global health awareness, the overall demand of the industry has steadily increased. The market in developed regions is mature and stable, and the demand for multi-functional, new materials and high value-added dressings is increasingly urgent; the medical industry in developing countries tends to be well developed, and the number of medical systems, health institutions and medical expenditures continue to rise, driving the demand for antimicrobial wound dressings to continue to grow.

Market Challenges

As a result of COVID-19, hospitals and clinics are severely limiting the ability of clinicians to see patients, including the closure of outpatient wound clinics. the spread of COVID-19 has led to a reduction in necessary medical services, including wound healing specialties, and has limited the ability to perform wound healing under normal circumstances. The spread of the pandemic has crowded out limited healthcare resources and healthcare providers have cancelled or postponed procedures for chronic conditions, resulting in an intermittent decline in market demand for antimicrobial wound dressings. In addition, production of antimicrobial wound dressings continued during the COVID-19 pandemic, but bottlenecks in shipping and distribution may have resulted in a continued lack of antimicrobial wound dressings in some downstream facilities.

Market Risks/Restraints

The percentage of antimicrobial wound dressings in developing countries is still low due to the high price of antimicrobial wound dressings and limited coverage in the medical system. With the rising number of diabetic ulcers and varicose ulcers due to the aging population trend, the market demand for emerging antimicrobial wound dressings is expected to continue to expand, and its penetration rate in developing countries is expected to continue to increase, with greater market potential in emerging countries.However, the sales of antimicrobial wound dressings are restricted by national policies and economical consumption concepts. In China, for example, the Chinese government's reform in the healthcare sector has caused an adverse impact on the sales volume and price of antimicrobial wound dressings. At the same time, guided by the economy-oriented consumer philosophy, Chinese consumers prefer lower-priced low-end products, resulting in poor sales of antimicrobial wound dressings. The hindrance of both sales and price of antimicrobial wound dressings has caused the industry to remain dominated by low-end products. At the same time, China's medical insurance policy does not include medical dressings in the reimbursement product catalog, and medical dressings cannot be charged separately but can only be included in the service charges, hospitals and patients are highly sensitive to its price, antimicrobial wound dressings market expansion difficulties.

Region Overview:

From 2022-2027, Europe is estimated to witness robust growth prospects.

Company Overview

The top three companies are 3M, Smith and Nephew and Molnlycke Health Care with the revenue market share of 19.24%, 14.83% and 13.01% in 2019. 3M is a technology company. The Company operates through four segments:Safety and Industrial, Transportation and Electronics, Health Care and Consumer. Safety and Industrial segment consist of personal safety, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules. Transportation and Electronics segment consists of electronics, including display materials and systems, electronic materials solutions, automotive and aerospace, commercial solutions, advanced materials, and transportation safety. Health Care segment's products and services include medical and surgical supplies, skin health and infection prevention products, oral care solutions, separation and purification sciences, health information systems and food safety products. Consumer segment serves consumers and consists of home improvement, stationery and office supplies, home care and consumer health care.Smith & Nephew is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Segmentation Overview:

As for product types, the Hydrocolloids segment held the largest market share in 2021.

Application Overview:

By application, the Surgical Wounds segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Antimicrobial Wound Dressing market covered in Chapter 3:

Coloplast A/SMolnlycke Health CarePaul HartmannConvaTec3MHollisterAdvanced Medical Solutions GroupLohmannand RauscherMedline IndustriesSmith and NephewDeRoyal IndustriesUrgo Medical (Laboratoires URGO)B.BraunEssityCovidien (Medtronic)

In Chapter 4 and Chapter 14.2, on the basis of types, the Antimicrobial Wound Dressing market from 2018 to 2029 is primarily split into:

HydrocolloidsAlginatesTransparent FilmHydrofiberOthers

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Antimicrobial Wound Dressing market from 2018 to 2029 covers:

Acute WoundsChronic WoundsSurgical Wounds

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)Latin America (Brazil, Mexico, Argentina)Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)